Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression

被引:143
作者
Mittelstadt, PR [1 ]
Ashwell, JD [1 ]
机构
[1] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1128/MCB.18.7.3744
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation-induced transcriptional upregulation of the ligand for Fas (FasL) and the resulting apoptosis of Fas-bearing cells constitute essential steps in a host of normal and pathological processes. Here we describe an activation-inducible cis acting regulatory element in the fasL promoter that is required for gene expression. Oligonucleotide competition and antibody supershift analyses identified two activation-induced DNA binding species: Egr-1 (NGFI-A, krox-24, zif268, TIS-I), a transcription factor that has been implicated in growth, differentiation, and apoptosis; and Egr-3 (PILOT), a transcription factor of no previously known function, Activation-induced expression of Egr-3, like that of FasL, was inhibited by cyclosporin A, whereas expression of Egr-1 was unaffected, Transient expression of Egr-3 alone increased fasL promoter activity in a cyclosporin A-insensitive manner, whereas expression of Egr-1 had little effect. Moreover, endogenous fast mRNA was induced in nonlymphoid cells by forced expression of Egr-3 in the absence of any other stimulus. These studies identify a critical Egr family-binding site in the fasL promoter and demonstrate that activation-induced Egr-3, but not Egr-1, directly upregulates fast transcription in response to activating stimuli.
引用
收藏
页码:3744 / 3751
页数:8
相关论文
共 67 条
  • [1] T-CELL RECEPTOR-INDUCED FAS LIGAND EXPRESSION IN CYTOTOXIC T-LYMPHOCYTE CLONES IS BLOCKED BY PROTEIN-TYROSINE KINASE INHIBITORS AND CYCLOSPORINE-A
    ANEL, A
    BUFERNE, M
    BOYER, C
    SCHMITTVERHULST, AM
    GOLSTEIN, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) : 2469 - 2476
  • [2] FAS-MEDIATED CYTOTOXICITY BY FRESHLY ISOLATED NATURAL-KILLER-CELLS
    ARASE, H
    ARASE, N
    SAITO, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) : 1235 - 1238
  • [3] AUSUBEL FM, 1997, CURRENT PROTOCOLS MO, V9
  • [4] Baumler CB, 1996, BLOOD, V88, P1741
  • [5] A ROLE FOR CD95 LIGAND IN PREVENTING GRAFT-REJECTION
    BELLGRAU, D
    GOLD, D
    SELAWRY, H
    MOORE, J
    FRANZUSOFF, A
    DUKE, RC
    [J]. NATURE, 1995, 377 (6550) : 630 - 632
  • [6] A VERY STRONG ENHANCER IS LOCATED UPSTREAM OF AN IMMEDIATE EARLY GENE OF HUMAN CYTOMEGALO-VIRUS
    BOSHART, M
    WEBER, F
    JAHN, G
    DORSCHHASLER, K
    FLECKENSTEIN, B
    SCHAFFNER, W
    [J]. CELL, 1985, 41 (02) : 521 - 530
  • [7] CELL-AUTONOMOUS FAS (CD95) FAS-LIGAND INTERACTION MEDIATES ACTIVATION-INDUCED APOPTOSIS IN T-CELL HYBRIDOMAS
    BRUNNER, T
    MOGIL, RJ
    LAFACE, D
    YOO, NJ
    MAHBOUBI, A
    ECHEVERRI, F
    MARTIN, SJ
    FORCE, WR
    LYNCH, DH
    WARE, CF
    GREEN, DR
    [J]. NATURE, 1995, 373 (6513) : 441 - 444
  • [8] Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506
    Brunner, T
    Yoo, NJ
    LaFace, D
    Ware, CF
    Green, DR
    [J]. INTERNATIONAL IMMUNOLOGY, 1996, 8 (07) : 1017 - 1026
  • [9] IDENTIFICATION AND CHARACTERIZATION OF THE EGR-1 GENE-PRODUCT, A DNA-BINDING ZINC FINGER PROTEIN-INDUCED BY DIFFERENTIATION AND GROWTH SIGNALS
    CAO, XM
    KOSKI, RA
    GASHLER, A
    MCKIERNAN, M
    MORRIS, CF
    GAFFNEY, R
    HAY, RV
    SUKHATME, VP
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (05) : 1931 - 1939
  • [10] The role of Fas in autoimmune diabetes
    Chervonsky, AV
    Wang, Y
    Wong, FS
    Visintin, I
    Flavell, RA
    Janeway, CA
    Matis, LA
    [J]. CELL, 1997, 89 (01) : 17 - 24